Cholesgen Enters Discovery Collaboration, Licensing Option Agreement With AstraZeneca
Shanghai – June 16, 2023 – Cooley advised Cholesgen, a biopharmaceutical company focusing on metabolic diseases, on its three-year research collaboration and licensing agreement with AstraZeneca. Partner Christina Zhang led the Cooley team advising Cholesgen.
The collaboration aims to validate genetic drug targets and develop therapeutic molecules into clinical development for hypercholesterolemia. Cholesgen is entitled to receive an initial payment, as well as a predefined license package for each qualified drug candidate nominated by AstraZeneca to progress into clinical development. This transaction establishes a new collaboration model with a Chinese biotech firm, starting from targets and mechanisms originally identified by Chinese researchers.
Cholesgen is a pioneer in biomedical research, innovative target identification and first-in-class drug discovery in the field of cholesterol-related diseases, such as hyperlipidemia, obesity, atherosclerosis and nonalcoholic steatohepatitis.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.